PALATIN TECHNOLOGIES, INC. Increase (Decrease) in Other Receivables
PALATIN TECHNOLOGIES, INC. (PTN) reported Increase (Decrease) in Other Receivables of $2.14 million for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2026-05-13
- PALATIN TECHNOLOGIES, INC. increase (decrease) in other receivables for the quarter ending 2026-03-31 was $2.17M.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in other receivables for the quarter ending 2025-12-31 was -$19.79K.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in other receivables for the quarter ending 2025-09-30 was -$9.68K.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in other receivables for the quarter ending 2025-06-30 was -$241.57K.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in other receivables for fiscal 2025 was $29.47K.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in other receivables for fiscal 2024 was $0.00.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 6 month as first filed | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | $2.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | $2.15M derived: sum of 2 quarters · filed 2026-05-13 | $2.14M 10-Q · filed 2026-05-13 | $1.90M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2025-12-31 | -$19.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-17 | -$29.47K 10-Q · filed 2026-02-17 | -$271.04K derived: sum of 3 quarters · filed 2026-02-17 | ||
| 2025-09-30 | -$9.68K 10-Q · filed 2025-11-14 | -$251.25K derived: sum of 2 quarters · filed 2025-11-14 | |||
| 2025-06-30 | -$241.57K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $29.47K 10-K · filed 2025-09-23 | |||
| 2025-03-31 | $271.04K 10-Q · filed 2026-05-13 | ||||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-11-14 | $0.00 derived: sum of 3 quarters · filed 2025-11-14 | ||
| 2024-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $0.00 derived: sum of 2 quarters · filed 2025-09-23 | $0.00 10-K · filed 2025-09-23 | ||
| 2024-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | $0.00 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | $0.00 10-Q · filed 2024-02-14 | ||||
| 2023-03-31 | $4.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-15 | $0.00 10-Q · filed 2023-05-15 | |||
| 2022-12-31 | -$4.67M 10-Q · filed 2024-02-14 | $4.67M 10-Q · filed 2023-02-14 | |||
| 2022-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-15 | $0.00 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | $0.00 10-Q · filed 2023-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |